Skip to main content

Table 1 Main characteristics of women included (hormone non-users only), overall and in discovery and validation sets

From: Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort

 

Overall (n = 2358)

Discovery (n = 1572)

Validation (n = 786)

Age at blood collection (years)

53.9 (8.5)

53.1 (8.6)

55.5 (8.1)

Fasting status at blood collectiona (%)

   

 No

936 (39.7)

639 (40.6)

297 (37.8)

 In between

375 (15.9)

252 (16.0)

123 (15.6)

 Yes

1047 (44.4)

681 (43.3)

366 (46.6)

Menopausal status at blood collection (%)

   

 Premenopausal

722 (30.6)

522 (33.2)

200 (25.4)

 Postmenopausal

1294 (54.9)

808 (51.4)

486 (61.8)

 Perimenopausal

342 (14.5)

242 (15.4)

100 (12.7)

Age at first menstrual periods (years) (mean (SD))

13.1 (1.6)

13.1 (1.6)

13.1 (1.6)

Number of full-term pregnancies (mean (SD))

2.1 (1.3)

2.0 (1.2)

2.1 (1.4)

Age at first full-term pregnancy (years) (mean (SD))

25.2 (4.3)

25.1 (4.4)

25.4 (4.2)

Breastfeeding (in parous women) (%)

   

 Yes

1669 (80.9)

1110 (80.7)

559 (81.2)

 No

280 (13.6)

181 (13.2)

99 (14.4)

 Missing

115 (5.6)

85 (6.2)

30 (4.4)

Ever used oral contraceptive (%)

1120 (47.5)

790 (50.3)

330 (42.0)

Ever used MHT (%)

297 (12.6)

198 (12.6)

99 (12.6)

Education level (%)

   

 Primary/no schooling

1162 (49.3)

743 (47.3)

419 (53.3)

 Technical/professional/secondary

819 (34.7)

560 (35.6)

259 (33.0)

 Longer education

377 (16.0)

269 (17.1)

108 (13.7)

Physical activity (Cambridge Index) (%)

   

 Inactive

623 (26.4)

388 (24.7)

235 (29.9)

 Moderately inactive

929 (39.4)

623 (39.6)

306 (38.9)

 Moderately active

450 (19.1)

307 (19.5)

143 (18.2)

 Active

356 (15.1)

254 (16.2)

102 (13.0)

Smoking status (%)

   

 Never

1406 (59.6)

934 (59.4)

472 (60.1)

 Former

480 (20.4)

299 (19.0)

181 (23.0)

 Smoker

472 (20.0)

339 (21.6)

133 (16.9)

Alcohol consumption at recruitment (%)

   

 Non-drinker

509 (21.6)

302 (19.2)

207 (26.3)

 > 0–3 g/day

707 (30.0)

482 (30.7)

225 (28.6)

 > 3–12 g/day

619 (26.3)

416 (26.5)

203 (25.8)

 > 12–24 g/day

337 (14.3)

239 (15.2)

98 (12.5)

 > 24 g/day

186 (7.9)

133 (8.5)

53 (6.7)

Height (cm) (mean (SD))

160.4 (6.8)

160.6 (6.7)

160.0 (6.8)

BMI (kg/m2) (mean (SD))

26.0 (4.3)

25.9 (4.3)

26.3 (4.4)

Waist circumference (cm) (mean (SD))

81.9 (10.6)

81.5 (10.4)

82.6 (10.9)

Waist/hip ratio (mean (SD))

0.80 (0.07)

0.80 (0.07)

0.81 (0.07)

Total energy intake (kcal/day) (mean (SD))

2010.3 (547.7)

2016.3 (557.6)

1998.3 (527.4)

Healthy Lifestyle Indexb (mean(SD))

12.6 (3.0)

12.6 (3.0)

12.8 (2.9)

WCRF/AICR scorec (mean (SD))

3.9 (1.0)

3.9 (1.0)

3.9 (1.0)

Modified Mediterranean diet score (mean (SD))

4.3 (1.8)

4.3 (1.8)

4.5 (1.7)

Inflammatory score of the diet (mean (SD))

0.9 (1.7)

0.89 (1.7)

0.8 (1.7)

Diet Quality Index-International (mean (SD))

57.4 (7.8)

57.2 (7.9)

57.8 (7.7)

Metabolite concentrations (normalized), μmol/L

   

 Arginine (geometric mean (SD))

64.1 (2.6)

64.2 (2.6)

63.9 (2.6)

 Asparagine (geometric mean (SD))

41.5 (2.7)

41.4 (2.7)

41.6 (2.7)

 C2 (geometric mean (SD))

4.9 (2.7)

4.9 (2.7)

4.9 (2.6)

 PC aa C36:3 (geometric mean (SD))

130.0 (2.6)

127.0 (2.6)

136.0 (2.7)

 PC ae C34:2 (geometric mean (SD))

12.2 (2.7)

12.1 (2.8)

12.4 (2.7)

 PC ae C36:2 (geometric mean (SD))

15.6 (2.7)

15.5 (2.7)

15.6 (2.7)

 PC ae C36:3 (geometric mean (SD))

8.1 (2.7)

8.0 (2.7)

8.2 (2.7)

 PC ae C38:2 (geometric mean (SD))

2.1 (2.7)

2.1 (2.7)

2.1 (2.8)

  1. Abbreviations: AICR American Institute for Cancer Research, BMI body mass index, C2 acetylcarnitine, MHT menopause hormone therapy, PC aa phosphatidylcholine diacyl, PC ae phosphatidylcholine acyl-alkyl, SD standard deviation, WCRF World Cancer Research Fund
  2. aNo: < 3 h since last meal (< 4 h in Umeå); in between: 3–6 h since last meal (4–8 h in Umeå); yes: > 6 h since last meal (> 8 h in Umeå)
  3. bHealthy Lifestyle Index was missing for 144 (6.1%) participants
  4. cWCRF/AICR score was missing for 196 (8.3%) participants